
Is Intelligent Bio Solutions (INBS) stock Halal?
Verdict for Intelligent Bio Solutions (INBS): not Shariah compliant (FAIL). Screened October 2026 under AAOIFI Shariah Standard No. 21. Business activity: pass. Non-permissible income: pass. Interest-bearing investments: fail. Interest-bearing debt: pass. Preference shares: pass. Dividend purification factor: not applicable. Next review: November 2026.
Intelligent Bio Solutions is a pioneering company in the biotechnology and medical technology sectors. The company's primary function is to advance health care solutions through the development of innovative, diagnostic technologies that focus on improving patient outcomes. It operates predominantly in the biosensor technology space, leveraging cutting-edge research and development to create highly sensitive diagnostic tools. For Muslim investors, though, the most pressing question is simpler: is Intelligent Bio Solutions a Halal investment?
Is Intelligent Bio Solutions Shariah compliant?
No. In the October 2026 screening Intelligent Bio Solutions (INBS) does not pass AAOIFI screening: it fails the interest-bearing investments screen. Medicines and medical devices are permissible, and healthcare companies like Intelligent Bio Solutions usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.
Does Intelligent Bio Solutions pass the business activity test?
The activity screen is only part of the picture this month: Intelligent Bio Solutions currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.
Is Intelligent Bio Solutions' income Halal?
Yes, within AAOIFI's tolerance. Intelligent Bio Solutions' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.
Does Intelligent Bio Solutions meet AAOIFI's debt and investment ratio requirements?
Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $5.54M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.
Why do other halal screeners show a different verdict for Intelligent Bio Solutions?
Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance










